BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Mar 31, 2018
Strategy

Refashioning Takeda

Acquisition of Shire would radically depart from Takeda’s strategy to date
BioCentury | Jan 12, 2018
Company News

Shire to split neuro and rare disease businesses

BioCentury | Jan 9, 2018
Company News

Shire splits neuro and rare disease businesses

BioCentury | Aug 4, 2017
Company News

Shire evaluating neurology pipeline

BioCentury | Aug 3, 2017
Company News

Shire evaluating neurology pipeline

BioCentury | Jun 23, 2017
Clinical News

FDA approves Shire's triple-bead ADHD therapy

BioCentury | Jun 21, 2017
Company News

FDA approves Shire's triple-bead ADHD therapy

Items per page:
1 - 7 of 7